MEDICINES / DRUGS

back

Phytotherapic to the topical treatment of cutaneous Leishmaniasis

Project 106

Problem to be solved:
• High toxicity of the medicine against Leishmaniasis
• Resistance of protozoa to available medicines

Proposed Innovation:
Phytotherapic made from physalins for topical treatment of cutaneous Leishmaniasis

Differential:
• Phytochemical with low toxicity
• Process with high yield and low operating cost
• Process free of toxic substances
• National raw material

Development status:
Prototype

Intellectual property status:
BRPI9904635-0 (correspondent granted in the U.S.)

Technology transfer status:
Partnership

Coordinator:
Milena Botelho Pereira Soares / CPqGM

Contact:
Gestec/VPPIS – Phone: 21 3882-9099 / 3882-9120 or portfolio@fiocruz.br